Search Results - "Svanera, Gino"

Use of rituximab in NHL malt type pregnant in I° trimester for two times by Sica, Antonello, Vitiello, Paola, Papa, Alfonso, Calogero, Armando, Sagnelli, Caterina, Casale, Danilo, Mottola, Maria, Svanera, Gino, Dodaro, Concetta Anna, Martinelli, Erika, Troiani, Teresa, Ciardiello, Fortunato, Casale, Beniamino

“…Administration of rituximab, one of the basic drugs for the therapy of B-cell lymphoproliferative diseases, during pregnancy has been suspected to cause…”
Get full text

How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report by Sica, Antonello, Sagnelli, Caterina, Casale, Beniamino, Svanera, Gino, Creta, Massimiliano, Calogero, Armando, Franco, Renato, Sagnelli, Evangelista, Ronchi, Andrea

“…The t (2; 5) chromosomal rearrangement of the ALK gene with nucleophosmin 1 gene (NPM1), resulting in an NPM1-ALK fusion, was first demonstrated in 1994 in…”
Get full text

Development of an Artificial-Intelligence-Based Tool for Automated Assessment of Cellularity in Bone Marrow Biopsies in Ph-Negative Myeloproliferative Neoplasms by D'Abbronzo, Giuseppe, D'Antonio, Antonio, De Chiara, Annarosaria, Panico, Luigi, Sparano, Lucianna, Diluvio, Anna, Sica, Antonello, Svanera, Gino, Franco, Renato, Ronchi, Andrea

“…The cellularity assessment in bone marrow biopsies (BMBs) for the diagnosis of Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms (MPNs) is a…”
Get full text

Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients by De Novellis, Danilo, Derudas, Daniele, Vincelli, Donatella, Fontana, Raffaele, Della Pepa, Roberta, Palmieri, Salvatore, Accardi, Fabrizio, Rotondo, Francesco, Morelli, Emanuela, Gigliotta, Emilia, Roccotelli, Daniela, Marano, Luana, Barone, Maria Lucia, Cetani, Giusy, Esposito, Daniela, Lazzaro, Antonio, Delle Cave, Giuseppe, Serio, Bianca, Morini, Denise, Porrazzo, Marika, Urciuoli, Eleonora, Masucci, Chiara, Fanelli, Fulvia, Rizzo, Michela, Arcamone, Manuela, Trastulli, Fabio, Rocco, Stefano, Leone, Aldo, Bianco, Rosario, Salvatore, Flavia, Idato, Aurora, Sicari, Maria, Tosi, Patrizia, Rascato, Maria Gabriella, Di Perna, Maria, Falcone, Antonietta Pia, Morello, Lucia, Carlisi, Melania, Svanera, Gino, Annunziata, Mario, Frigeri, Ferdinando, Califano, Catello, Carella, Angelo Michele, Marcacci, Gianpaolo, Pane, Fabrizio, Risitano, Antonio Maria, Giudice, Valentina, Botta, Ciro, Selleri, Carmine

“…Isatuximab, a novel anti-CD38 monoclonal antibody, is approved in combination with carfilzomib and dexamethasone (Isa-Kd) in relapsed/refractory multiple…”
Get full text

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience by De Novellis, Danilo, Fontana, Raffaele, Palmieri, Salvatore, Della Pepa, Roberta, Di Perna, Maria, Cetani, Giusy, Esposito, Daniela, Amendola, Angela, Delle Cave, Giuseppe, Serio, Bianca, Morini, Denise, Rizzo, Michela, Mettivier, Laura, Trastulli, Fabio, Rocco, Stefano, Pagano, Anastasia, Barbato, Serafina, Leone, Aldo, La Magna, Martina, Bianco, Rosario, Rascato, Gabriella, Carobene, Angela, Cuffa, Bianca, Iannalfo, Marialuigia, Giudice, Valentina, Svanera, Gino, Annunziata, Mario, Pizzuti, Michele, Frigeri, Ferdinando, Califano, Catello, Ferrara, Felicetto, Pane, Fabrizio, Selleri, Carmine

“…Background Daratumumab, an anti-CD38 monoclonal antibody, is used for treatment of multiple myeloma (MM) and light chain amyloidosis at an intravenous dosage…”
Get full text

Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma by Russo, Filippo, Lastoria, Secondo, Svanera, Gino, Capobianco, Gaetana, de Chiara, Anna, di Francia, Raffaele, Squame, Elisabetta, de Martinis, Franco, Pinto, Antonio

“…The present study has explored the possible value of sCA-125 as a prognostic factor in Hodgkin's lymphoma (HL). From August 1992 to June 2005 sCA-125 was…”
Get full text

The Impact of Relative Dose Intensity on Response and Survival in a Series of 180 Newly Diagnosed Patients with Hodgkin's Lymphoma by Russo, Filippo, Svanera, Gino, Cioppa, Paola Della, Corazzelli, Gaetano, Frigeri, Ferdinando, Capobianco, Gaetana, LaStoria, Secondo, Pinto, Antonio

“…To improve ABVD results we first developed a protocol which adds G-CSF to the standard ABVD treatment. From March 1997 to May 2004 69 patients with HL were…”
Get full text

How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report by Sica, Antonello, Sagnelli, Caterina, Casale, Beniamino, Svanera, Gino, Creta, Massimiliano, Calogero, Armando, Franco, Renato, Sagnelli, Evangelista, Ronchi, Andrea

“…BACKGROUNDThe t (2; 5) chromosomal rearrangement of the ALK gene with nucleophosmin 1 gene (NPM1), resulting in an NPM1-ALK fusion, was first demonstrated in…”
Get full text